John Maki

John Maki

Board Member at BioNJ

Are you John Maki? Claim your profile
 
  • IDENTIFY executive and board member connections in John Maki's network.
  • FOLLOW changes in John Maki's employment.
  • CONNECT with John Maki through your network of contacts.

John Maki's Executive Work History


Current
Board Member,
Board Member
Equilar on 01/18/2023
BioNJ
Advisor,
Advisor
Equilar on 11/19/2022
ConSynance Therapeutics
Past
To view John Maki's complete executive work history,
Education
B.A., Harvard University
 

John Maki's Biography


Mr. Maki previously served as CEO of Vicus Therapeutics, as Managing Director of Technology Directors, Inc., as Managing Director of Audax Group and as Principal, Bain Capital, as well as a consultant for Bain & Company. Mr. Maki holds an AB degree from Harvard University. He has over 25 years of industry experience and has been a founding investor and/or board member of 11 life sciences companies. In addition, four of Mr. Maki’s portfolio companies had successful IPOs and grew to a combined market capitalization exceeding $2.5 billion dollars. Mr. Maki currently serves on the boards of Vicus Therapeutics, an immuno-oncology company and 3DMatrix, a wound healing device company.

Source: BioNJ on 01/18/2023

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like John Maki. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in John Maki's network.
  • FOLLOW changes in John Maki's employment.
  • CONNECT with John Maki through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: John Maki

John Maki's Connections (35)


Leigh Anne Leas
Former Board Member, BioNJ
Carrie Brown
Board Member, BioNJ
Christian Kopfli Esq.
Former Board Member, BioNJ
George F. Heinrich
Board Member, KayoThera, Inc.
Investor Advisor
Board Member, BioNJ
Michele Ilene Korfin
Chief Operating and Chief Commercial Officer, Gamida Cell Ltd.
Marco Taglietti M.D.
President, Chief Executive Officer and Director, SCYNEXIS, Inc.
Shuang Liu
Founder & Chief Executive Officer, ConSynance Therapeutics
Amadou Diarra Ph.D.
Board Member, BioNJ
Scott Megaffin
Chief Executive Officer, Adastra Pharmaceuticals Inc.